{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:39:11Z","timestamp":1787503151453,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"David Telling Charitable Trust","award":["72508"],"award-info":[{"award-number":["72508"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pre-eclampsia and being born small for gestational age are associated with significant maternal and neonatal morbidity and mortality. Placental dysfunction is a key pathological process underpinning these conditions; thus, markers of placental function have the potential to identify pregnancies ending in pre-eclampsia, fetal growth restriction, and the birth of a small for gestational age infant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary objective<\/jats:title>\n                    <jats:p>To assess the predictive ability of late pregnancy (after 24 weeks\u2019 gestation) tests in isolation or in combination for adverse pregnancy outcomes associated with placental dysfunction, including pre-eclampsia, fetal growth restriction, delivery of a SGA infant (more specifically neonatal growth restriction), and stillbirth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies assessing the ability of biochemical tests of placental function and\/or ultrasound parameters in pregnant women beyond 24 weeks\u2019 gestation to predict outcomes including pre-eclampsia, stillbirth, delivery of a SGA infant (including neonatal growth restriction), and\/or fetal growth restriction will be identified by searching the following databases: EMBASE, MEDLINE, Cochrane CENTRAL, Web of Science, CINAHL, ISRCTN registry, UK Clinical Trials Gateway, and WHO International Clinical Trials Portal. Any study design in which the biomarker and ultrasound scan potential predictors have been assessed after 24 weeks\u2019 gestation but before diagnosis of outcomes (pre-eclampsia, fetal growth restriction, SGA (including neonatal growth restriction), and stillbirth) will be eligible (this would include randomized control trials and nested prospective case-control and cohort studies), and there will be no restriction on the background risk of the population. All eligible studies will be assessed for risk of bias using the modified QUADAS-2 tool. Meta-analyses will be undertaken using the ROC models to estimate and compare test discrimination and reclassification indices to test calibration. Validation will be explored by comparing consistency across studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This review will assess whether current published data reporting either a single or combination of tests in late pregnancy can accurately predict adverse pregnancy outcome(s) associated with placental dysfunction. Accurate prediction could allow targeted management and possible intervention for high-risk pregnancies, ultimately avoiding adverse outcomes associated with placental disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      PROSPERO\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=107049\">CRD42018107049<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-020-01334-5","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:02:37Z","timestamp":1586314957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies"],"prefix":"10.1186","volume":"9","author":[{"given":"Melanie","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E. P.","family":"Heazell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"issue":"9774","key":"1334_CR1","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(10)62233-7","volume":"377","author":"V Flenady","year":"2011","unstructured":"Flenady V, Koopmans L, Middleton P, Froen JF, Smith GC, Gibbons K, Coory M, Gordon A, Ellwood D, McIntyre HD, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377(9774):1331\u201340.","journal-title":"Lancet"},{"issue":"5","key":"1334_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/1471-0528.12517","volume":"121","author":"GL Malin","year":"2014","unstructured":"Malin GL, Morris RK, Riley R, Teune MJ, Khan KS. When is birthweight at term abnormally low? A systematic review and meta-analysis of the association and predictive ability of current birthweight standards for neonatal outcomes. BJOG. 2014;121(5):515\u201326.","journal-title":"BJOG"},{"key":"1334_CR3","unstructured":"Harding K, Redmond P, Tuffnell D: Caring for women with hypertensive disorders of pregnancy. MBRRACE-UK Saving Lives, Improving Mothers\u2019 Care - Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Con dential Enquiries into Maternal Deaths and Morbidity 2009-14 2016(Oxford):69-75."},{"issue":"6","key":"1334_CR4","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, Gulmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u201333.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"1334_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","volume":"51","author":"B Huppertz","year":"2008","unstructured":"Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970\u20135.","journal-title":"Hypertension"},{"issue":"8","key":"1334_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.placenta.2014.05.011","volume":"35","author":"I Ptacek","year":"2014","unstructured":"Ptacek I, Sebire NJ, Man JA, Brownbill P, Heazell AE. Systematic review of placental pathology reported in association with stillbirth. Placenta. 2014;35(8):552\u201362.","journal-title":"Placenta"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.placenta.2016.04.020","volume":"43","author":"KJ Gibbins","year":"2016","unstructured":"Gibbins KJ, Silver RM, Pinar H, Reddy UM, Parker CB, Thorsten V, Willinger M, Dudley DJ, Bukowski R, Saade GR, et al. Stillbirth, hypertensive disorders of pregnancy, and placental pathology. Placenta. 2016;43:61\u20138.","journal-title":"Placenta"},{"issue":"5","key":"1334_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/uog.17289","volume":"48","author":"S Mastrodima","year":"2016","unstructured":"Mastrodima S, Akolekar R, Yerlikaya G, Tzelepis T, Nicolaides KH. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks. Ultrasound Obstet Gynecol. 2016;48(5):613\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"Suppl 1","key":"1334_CR9","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.placenta.2014.12.017","volume":"36","author":"AE Heazell","year":"2015","unstructured":"Heazell AE, Worton SA, Higgins LE, Ingram E, Johnstone ED, Jones RL, Sibley CP. IFPA Gabor than award lecture: recognition of placental failure is key to saving babies\u2019 lives. Placenta. 2015;36(Suppl 1):S20\u20138.","journal-title":"Placenta"},{"issue":"6","key":"1334_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/1471-0528.12172","volume":"120","author":"A Conde-Agudelo","year":"2013","unstructured":"Conde-Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG. 2013;120(6):681\u201394.","journal-title":"BJOG"},{"issue":"1","key":"1334_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/1471-0528.13096","volume":"122","author":"A Conde-Agudelo","year":"2015","unstructured":"Conde-Agudelo A, Bird S, Kennedy SH, Villar J, Papageorghiou AT. First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis. BJOG. 2015;122(1):41\u201355.","journal-title":"BJOG"},{"issue":"2","key":"1334_CR12","first-page":"142","volume":"34","author":"D Hui","year":"2012","unstructured":"Hui D, Okun N, Murphy K, Kingdom J, Uleryk E, Shah PS. Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review. JOGC. 2012;34(2):142\u201353.","journal-title":"JOGC"},{"issue":"4","key":"1334_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/OGX.0b013e3182227027","volume":"66","author":"S Kuc","year":"2011","unstructured":"Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GHA, Schielen PCJI. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66(4):225\u201339.","journal-title":"Obstet Gynecol Surv"},{"issue":"6","key":"1334_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.placenta.2012.03.003","volume":"33","author":"G Di Lorenzo","year":"2012","unstructured":"Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Brumatti LV, Montico M, D\u2019Ottavio G. First trimester maternal serum PIGF, HCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta. 2012;33(6):495\u2013501.","journal-title":"Placenta"},{"issue":"2","key":"1334_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000321694","volume":"29","author":"G Karagiannis","year":"2011","unstructured":"Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11\u201313 weeks. Fetal Diagn Ther. 2011;29(2):148\u201354.","journal-title":"Fetal Diagn Ther"},{"issue":"19","key":"1334_CR16","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","volume":"128","author":"LC Chappell","year":"2013","unstructured":"Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, Simpson N, Waugh J, Anumba D, Kenny LC, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013;128(19):2121\u201331.","journal-title":"Circulation"},{"issue":"1","key":"1334_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13\u201322.","journal-title":"N Engl J Med"},{"issue":"3","key":"1334_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/uog.17490","volume":"51","author":"M Griffin","year":"2018","unstructured":"Griffin M, Seed PT, Duckworth S, North R, Myers J, Mackillop L, Simpson N, Waugh J, Anumba D, Kenny LC, et al. Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia. Ultrasound Obstet Gynecol. 2018;51(3):387\u201395.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"1334_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","volume":"69","author":"U Sovio","year":"2017","unstructured":"Sovio U, Gaccioli F, Cook E, Hund M, Charnock-Jones DS, Smith GC. Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women. Hypertension. 2017;69(4):731\u20138.","journal-title":"Hypertension"},{"issue":"2","key":"1334_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/uog.14928","volume":"47","author":"N Valino","year":"2016","unstructured":"Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH. Biophysical and biochemical markers at 30-34 weeks\u2019 gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2016;47(2):194\u2013202.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"682.e1","DOI":"10.1016\/j.ajog.2017.10.001","volume":"217","author":"T Chaiworapongsa","year":"2017","unstructured":"Chaiworapongsa T, Romero R, Erez O, Tarca AL, Conde-Agudelo A, Chaemsaithong P, Kim CJ, Kim YM, Kim JS, Yoon BH, et al. The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF\/sVEGFR-1 ratio). Am J Obstet Gynecol. 2017;217:682.e1\u201313.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"1334_CR22","doi-asserted-by":"publisher","first-page":"287 e281","DOI":"10.1016\/j.ajog.2013.01.016","volume":"208","author":"T Chaiworapongsa","year":"2013","unstructured":"Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, et al. Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol. 2013;208(4):287 e281\u201315.","journal-title":"Am J Obstet Gynecol"},{"key":"1334_CR23","first-page":"CD011202","volume":"11","author":"AE Heazell","year":"2015","unstructured":"Heazell AE, Whitworth M, Duley L, Thornton JG. Use of biochemical tests of placental function for improving pregnancy outcome. Cochrane Database Syst Rev. 2015;11:CD011202.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1334_CR24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","volume":"119","author":"CE Kleinrouweler","year":"2012","unstructured":"Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, Bossuyt PM, van der Post JA, von Dadelszen P, Mol BW, Pajkrt E, Collaboration EC. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG. 2012;119(7):778\u201387.","journal-title":"BJOG"},{"key":"1334_CR25","unstructured":"Taskforce on Hypertension in Pregnancy: Hypertension in pregnancy practice guideline. WQ 244. American College of Obstetricians and Gynecologists 2013."},{"issue":"3","key":"1334_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/uog.15884","volume":"48","author":"SJ Gordijn","year":"2016","unstructured":"Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, Silver RM, Wynia K, Ganzevoort W. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpeds.2017.12.059","volume":"196","author":"IM Beune","year":"2018","unstructured":"Beune IM, Bloomfield FH, Ganzevoort W, Embleton ND, Rozance PJ, van Wassenaer-Leemhuis AG, Wynia K, Gordijn SJ. Consensus based definition of growth restriction in the newborn. J Pediatr. 2018;196:71\u20136 e71.","journal-title":"J Pediatr"},{"issue":"8","key":"1334_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, Group Q. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"19","key":"1334_CR29","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865\u201384.","journal-title":"Stat Med"},{"issue":"10","key":"1334_CR30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982\u201390.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"1334_CR31","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jclinepi.2006.06.011","volume":"59","author":"H Chu","year":"2006","unstructured":"Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol. 2006;59(12):1331\u20132.","journal-title":"J Clin Epidemiol"},{"issue":"24","key":"1334_CR32","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1002\/sim.8301","volume":"38","author":"HE Jones","year":"2019","unstructured":"Jones HE, Gatsonsis CA, Trikalinos TA, Welton NJ, Ades AE. Quantifying how diagnostic test accuracy depends on threshold in a meta-analysis. Stat Med. 2019;38(24):4789\u2013803.","journal-title":"Stat Med"},{"issue":"1","key":"1334_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12874-016-0196-1","volume":"16","author":"S Steinhauser","year":"2016","unstructured":"Steinhauser S, Schumacher M, Rucker G. Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies. BMC Med Res Methodol. 2016;16(1):97.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"1334_CR34","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","volume":"10","author":"EL Anderson","year":"2015","unstructured":"Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One. 2015;10(10):e0140908.","journal-title":"PLoS One"},{"key":"1334_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2288-14-5","volume":"14","author":"D van Klaveren","year":"2014","unstructured":"van Klaveren D, Steyerberg EW, Perel P, Vergouwe Y. Assessing discriminative ability of risk models in clustered data. BMC Med Res Methodol. 2014;14:5.","journal-title":"BMC Med Res Methodol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01334-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-020-01334-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-020-01334-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T19:25:07Z","timestamp":1617823507000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-020-01334-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1186\/s13643-020-01334-5","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"AH is the Chief Investigator of ReMIT2, a pilot randomized controlled trial of sFlt-1\/PlGF ratio in the management of women presenting with reduced fetal movements. He has no competing financial interests to declare.MG, LCC, and JZ have no competing interests to declare.DAL has received research support from Medtronic Ltd and Roche Diagnostics for research unrelated to this protocol or the planned systematic review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}